| 1 |
34970839 | Comparative proteome analysis identified CD44 as a possible serum marker for docetaxel resistance in castration-resistant prostate cancer. | 2022 Feb |
3 |
| 2 |
34236115 | Effects of miR-224-5p-enhanced downregulation of pannexin-1 on docetaxel-induced apoptosis in amoeboid-like CD44high oral cancer cells. | 2021 Oct |
2 |
| 3 |
30993586 | Midkine silencing enhances the anti-prostate cancer stem cell activity of the flavone apigenin: cooperation on signaling pathways regulated by ERK, p38, PTEN, PARP, and NF-κB. | 2020 Apr |
1 |
| 4 |
31273630 | Altered Expression of CD44, SIRT1, CXCR4, miR-21, miR-34a, and miR-451 Genes in MKN-45 Cell Line After Docetaxel Treatment. | 2020 Jun |
6 |
| 5 |
32223952 | Frequency of CD44 positive cells in MKN45 cell line after treatment with docetaxel in two and three-dimensional cell cultures. | 2020 Apr |
3 |
| 6 |
32642575 | CD44v8-10 mRNA contained in serum exosomes as a diagnostic marker for docetaxel resistance in prostate cancer patients. | 2020 Jul |
1 |
| 7 |
32985018 | CD44+ cells determine fenofibrate-induced microevolution of drug-resistance in prostate cancer cell populations. | 2020 Sep 27 |
9 |
| 8 |
30935014 | CD44 Promotes Migration and Invasion of Docetaxel-Resistant Prostate Cancer Cells Likely via Induction of Hippo-Yap Signaling. | 2019 Mar 30 |
5 |
| 9 |
30148955 | Co-delivery of Docetaxel and Disulfonate Tetraphenyl Chlorin in One Nanoparticle Produces Strong Synergism between Chemo- and Photodynamic Therapy in Drug-Sensitive and -Resistant Cancer Cells. | 2018 Oct 1 |
1 |
| 10 |
32254339 | Reduction-responsive core-crosslinked hyaluronic acid-b-poly(trimethylene carbonate-co-dithiolane trimethylene carbonate) micelles: synthesis and CD44-mediated potent delivery of docetaxel to triple negative breast tumor in vivo. | 2018 May 21 |
1 |
| 11 |
28418843 | CD24 Expression and differential resistance to chemotherapy in triple-negative breast cancer. | 2017 Jun 13 |
1 |
| 12 |
28859899 | Combination of using prodrug-modified cationic liposome nanocomplexes and a potentiating strategy via targeted co-delivery of gemcitabine and docetaxel for CD44-overexpressed triple negative breast cancer therapy. | 2017 Oct 15 |
1 |
| 13 |
29029419 | CD44 regulates prostate cancer proliferation, invasion and migration via PDK1 and PFKFB4. | 2017 Sep 12 |
1 |
| 14 |
29190901 | KIF11 is required for proliferation and self-renewal of docetaxel resistant triple negative breast cancer cells. | 2017 Nov 3 |
1 |
| 15 |
27473554 | Fabrication and biological evaluation of chitosan coated hyaluronic acid-docetaxel conjugate nanoparticles in CD44(+) cancer cells. | 2016 Jul 29 |
2 |
| 16 |
25648974 | Hyaluronan-decorated polymer nanoparticles targeting the CD44 receptor for the combined photo/chemo-therapy of cancer. | 2015 Mar 19 |
2 |
| 17 |
24444042 | CD44-targeted docetaxel conjugate for cancer cells and cancer stem-like cells: a novel hyaluronic acid-based drug delivery system. | 2014 Jun |
3 |
| 18 |
24643931 | Uptake and cytotoxicity of docetaxel-loaded hyaluronic acid-grafted oily core nanocapsules in MDA-MB 231 cancer cells. | 2014 Sep |
2 |
| 19 |
24659820 | Epithelial-to-mesenchymal transition mediates docetaxel resistance and high risk of relapse in prostate cancer. | 2014 May |
1 |
| 20 |
23301003 | Noninvasive identification of viable cell populations in docetaxel-treated breast tumors using ferritin-based magnetic resonance imaging. | 2013 |
1 |
| 21 |
23368632 | Evaluation of characteristics of CD44+CD117+ ovarian cancer stem cells in three dimensional basement membrane extract scaffold versus two dimensional monocultures. | 2013 Jan 31 |
1 |
| 22 |
23715169 | A tissue-engineered gastric cancer model for mechanistic study of anti-tumor drugs. | 2013 Aug |
1 |
| 23 |
22870202 | In vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147. | 2012 |
4 |
| 24 |
21376257 | Identification of cancer stem-like CD44+ cells in human nasopharyngeal carcinoma cell line. | 2011 Jan |
2 |
| 25 |
21733572 | Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxel. | 2011 Oct |
2 |
| 26 |
20074368 | Stable alterations of CD44 isoform expression in prostate cancer cells decrease invasion and growth and alter ligand binding and chemosensitivity. | 2010 Jan 14 |
1 |
| 27 |
20179163 | Cytotoxic effects induced by docetaxel, gefitinib, and cyclopamine on side population and nonside population cell fractions from human invasive prostate cancer cells. | 2010 Mar |
1 |
| 28 |
21139802 | Cell adhesion molecule CD44: its functional roles in prostate cancer. | 2010 Sep 12 |
1 |
| 29 |
19666588 | Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. | 2009 Aug 18 |
1 |
| 30 |
9499461 | Docetaxel treatment of HT-29 colon carcinoma cells reinforces the adhesion and immunocytotoxicity of peripheral blood lymphocytes in vitro. | 1998 Apr |
1 |